DARA BioSciences, Inc. Names Stephen Jaeger to Board

Published: Jul 19, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (Nasdaq: DARA) announced today the appointment of Stephen O. Jaeger to the DARA board of directors. Mr. Jaeger has served on the boards of a variety of private and public companies across the biopharmaceutical, medical, financial and other industries. “Steve is a thorough professional with extensive operating experience and a deep understanding of public companies, particularly in the area of pharmaceuticals and biotechnology,” said Dr. David J. Drutz, DARA’s chief executive officer. “His strategic, managerial and financial skills combined with his knowledge regarding specialty products will be of paramount importance as we grow our business. We look forward to Steve’s involvement as we prepare for the upcoming launch of Soltamox®. Furthermore, Steve’s contacts and experience will be invaluable as the company executes on its plan to continue building its sales and marketing pipeline.”

Back to news